GIST trial
Credit: OHSU/Kristyna Wentz-Graff
Diana Dowd, left, talks with Michael Heinrich, M.D., during an appointment at OHSU, Jan. 8, 2020. Dowd took part in a clinical trial treating a rare stomach cancer, GIST, which was recently approved by the FDA. Along with Dowd is her friend, Lauri Roskamp, center. (OHSU/Kristyna Wentz-Graff)